Germany - Drugs

Description

IKK classic hereby announces that it will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies in the period from 01.01.2023 to 31.12.2024 for various active ingredients and combinations of active ingredients on equal, non-negotiable terms in accordance with Section 130a (8) of the German Social Code Book V. The earliest contract start date is 01.01.2023, provided that the signed contract and all necessary evidence, self-declarations and documents are received by IKK classic by 05.12.2022. Thereafter, the following applies: If the documents are received by the 05th of a respective month in the possible accession period, the contract will start on the 01st of the following month. If the documents are received after the 5th of the respective month in the possible accession period, the contract will begin on the 1st of the month after the next. Accession to the agreement is possible at any time during the specified period, but no later than 05.11.2024. For further details, see section VI.3).
Ciclosporin; ATC code: L04AD01 Desmopressin; nasal spray, oral lyophilizate;ATC code: H01BA02 Diclofenac eye drops;ATC code: S01BC03 Enoxaparin; ATC Code: B01AB05 Estradiol valerate; ATC code: G03CA03 Etanercept; ATC Code: L04AB01 famciclovir; ATC code: J05AB09 isosorbide dinitrate; ATC code: C01DA08 lanreotide; ATC code: H01CB03 lenograstim; ATC code: L03AA10 Lipegfilgrastim; ATC code: L03AA14 liraglutide; ATC Code: A10BJ02 megestrol; ATC code: L02AB01 porcine pancreatic powder (multienzyme) 20,000; 25,000 I.U.;ATC code: A09AA02 sevelamer hydrochloride;ATC Code: V03AE02 somatropin; ATC Code: H01AC01 Tacrolimus peroral; ATC code: L04AD02 tapentadol; ATC code: N02AX06 timolol and dorzolamide single-dose pipettes;ATC code: S01ED66 Triamcinolone dermatological use;ATC code: D07AB09

Opportunity closing date

05 November 2024

Value of contract

£0-100k